
|Poll|June 21, 2023
POLL: What Topic Are You Most Looking Forward to at SDPA Summer 2023?
Author(s)Emma Andrus, Assistant Editor
Click here to answer today's poll.
Advertisement
What topic are you most looking forward to at SDPA?
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Phase 2b Analysis Shows Consistent Vitiligo Repigmentation With Ritlecitinib
2
FDA Grants Breakthrough Therapy Designation to Litifilimab for Cutaneous Lupus Erythematosus
3
Dual ITK/JAK3 Inhibition Shows Strong Preclinical Activity in Severe Alopecia Areata
4
Litifilimab Shows Early Skin Benefits in CLE
5










